SLCO1B1 polymorphisms affect atorvastatin pharmacokinetics and cholesterol-lowering effects in patients with hypercholesterolemia in a microdosing approach

医学 SLCO1B1型 阿托伐他汀 药理学 药代动力学 内科学 他汀类 药物遗传学 载脂蛋白E
作者
Kouji Kajinami,Kenji Takeda,Kazuya Maeda,Yuichi Sugiyama,Ichiro Ieiri,T. Masaugi,N. Fukizawa
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:34 (suppl 1): 140-140 被引量:1
标识
DOI:10.1093/eurheartj/eht307.140
摘要

Background: Atorvastatin is taken up into hepatocytes via organic anion transporting polypeptide (OATP). SLCO1B1 (encoding OATP1B1) 521T>C polymorphism has been reported to increase significantly its plasma AUC of in healthy volunteers. However, effects of SLCO1B1*15 (388A>G and 521T>C) on its pharmacokinetics and cholesterol-lowering effects in patients with hypercholesterolemia remain to be investigated. A microdosing approach can avoid the unexpected high concentrations of drugs in certain populations during pharmacogenetic or drug interaction studies. Therefore, we examined feasibility of clinical microdosing pharmacogenetic study in real clinical settings. Methods: Statin-naive patients (n=47, M/F=37/10, mean age 69yr) clinically indicated to LDL cholesterol-lowering therapy with atorvastatin were enrolled in a two-period crossover study. In the first period, microdose (100 ug) of atorvastatin was orally administered and blood was collected up to following 24 hrs. After washout for 1-2 days, therapeutic dose (10 mg) of atorvastatin was orally administered and its pharmacokinetics was monitored in the similar manner, with all concomitant medications. Results: The AUC/Dose of atorvastatin at microdose was smallerthan that at therapeutic dose (204±139 vs. 445±210 pg·hr/ml/100 ug), suggesting the saturation of efflux transporters. The plasma concentration of atorvastatin in subjects with SLCO1B1*15 was significantly greater both at microdose and therapeutic dose (+73% and +80%, p<0.05), which was associated with smaller %LDL-cholesterol lowering after 6 months (-33% and -25%, p<0.1). Conclusions: In real clinical settings, microdosing pharmacogenetic study appears to be feasible and could predict plasma AUC of atorvastatin at a therapeutic dose and the magnitude of LDL-cholesterol lowering in hypercholesterolemic subjects with SLCO1B1*15.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
plasmid完成签到,获得积分10
刚刚
Ava应助咕噜咕噜咕嘟咕嘟采纳,获得10
刚刚
1秒前
SHAO应助一块司康饼采纳,获得100
1秒前
嗯哼发布了新的文献求助10
1秒前
Rondab应助mariawang采纳,获得10
3秒前
MchemG应助酷酷的紫南采纳,获得30
4秒前
1111发布了新的文献求助10
4秒前
4秒前
continue发布了新的文献求助10
5秒前
zhangtong发布了新的文献求助10
5秒前
嘟嘟完成签到,获得积分10
5秒前
wdy111应助葡萄味的果茶采纳,获得20
6秒前
悦耳代真完成签到,获得积分10
6秒前
ysx完成签到,获得积分10
6秒前
7秒前
Orange应助淡淡夕阳采纳,获得10
7秒前
7秒前
yar重新开启了yl文献应助
8秒前
9秒前
9秒前
zhoup完成签到,获得积分20
10秒前
宝海青完成签到,获得积分10
10秒前
李健应助缓慢的含双采纳,获得10
10秒前
yqb完成签到,获得积分10
11秒前
上官若男应助笑点低的不采纳,获得10
12秒前
量子星尘发布了新的文献求助10
13秒前
qifunongsuo1213完成签到,获得积分10
13秒前
chenzixin发布了新的文献求助10
13秒前
13秒前
明理致远发布了新的文献求助10
13秒前
yqb发布了新的文献求助10
13秒前
14秒前
alex完成签到,获得积分10
14秒前
研友_VZG7GZ应助受伤翠容采纳,获得10
14秒前
暖羊羊Y完成签到 ,获得积分10
15秒前
李健的小迷弟应助铁盐君采纳,获得10
16秒前
沉默曼文完成签到,获得积分10
16秒前
火火完成签到 ,获得积分10
17秒前
脑洞疼应助玛卡巴卡采纳,获得10
17秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988732
求助须知:如何正确求助?哪些是违规求助? 3531027
关于积分的说明 11252281
捐赠科研通 3269732
什么是DOI,文献DOI怎么找? 1804764
邀请新用户注册赠送积分活动 881869
科研通“疑难数据库(出版商)”最低求助积分说明 809021